Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Mary A. Parks"'
Autor:
Katharina M. Scheurlen, Dylan L. Snook, Andrew B. Littlefield, Joan B. George, Mary A. Parks, Robert J. Beal, Anne MacLeod, Daniel W. Riggs, Jeremy T. Gaskins, Julia Chariker, Eric C. Rouchka, Susan Galandiuk
Publikováno v:
Cancer Medicine, Vol 12, Iss 23, Pp 21172-21187 (2023)
Abstract Aims Macrophages play an essential role in cancer development. Tumor‐associated macrophages (TAMs) have predominantly M2‐like attributes that are associated with tumor progression and poor patient survival. Numerous methods have been rep
Externí odkaz:
https://doaj.org/article/a63f5305656048768887b66870c986aa
Autor:
Meghan M. Fawcett, Mary C. Parks, Alice E. Tibbetts, Jane S. Swart, Elizabeth M. Richards, Juan Camilo Vanegas, Meredith Cenzer, Laura Crowley, William R. Simmons, Wenzhen Stacey Hou, David R. Angelini
Publikováno v:
Nature Communications, Vol 9, Iss 1, Pp 1-11 (2018)
The red-shouldered soapberry bug, Jadera haematoloma, is a potential model system for developmental plasticity. Here, the authors show that the reaction norm for wing polyphenism has evolved in a recently derived ecotype and identify insulin signalin
Externí odkaz:
https://doaj.org/article/a00eb067ae5a48faa72465a89e17d4ce
Autor:
Kaitlyn Mary Ann Parks, Janis Oram Cardy, Tiffany G. Woynaroski, Claudia Sehl, Ryan A Stevenson
The current study parsed out the distinct components of attention-deficit/hyperactivity disorder (ADHD) symptomatology to examine differential relations with language and social ability. Using a research domain criteria (RDoC) framework, we administe
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3e5b5cb2b714272f43281be4996ed868
https://doi.org/10.31234/osf.io/r4fdp
https://doi.org/10.31234/osf.io/r4fdp
Autor:
Noah J. Brierley, Christina G McDonnell, Kaitlyn Mary Ann Parks, Samantha Schulz, Tyler C. Dalal, Elizabeth Kelley, Evdokia Anagnostou, Robert Nicolson, Stelios Georgiades, Jennifer Crosbie, Russell Schachar, Xudong Liu, Ryan A Stevenson
Background: Autism spectrum disorder (ASD) and attention-deficit/hyperactivity disorder (ADHD) show high rates of comorbidity. Restricted interests and repetitive behaviors (RRBs) are a core symptom of ASD and commonly occur in ADHD. However, little
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::74857f30f53894cd0833e7fb9f9ab078
https://doi.org/10.31234/osf.io/5u23q
https://doi.org/10.31234/osf.io/5u23q
Publikováno v:
Singapore Journal of Tropical Geography. 37:6-24
Scientists often turn to farmers to understand soil management. This process reveals differences and overlaps between local and scientific soil knowledge but rarely considers women and gender issues. This paper examines men's and women's local knowle
This research identifies gender-based constraints and opportunities for the adoption of conservation agriculture production systems based on a case-study with smallholder farmers in two villages in Misamis Oriental, Northern Mindanao, Philippines. Us
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6e1fe9096bb26b9f69224230fbc6c71
https://hdl.handle.net/10919/70268
https://hdl.handle.net/10919/70268
Publikováno v:
New England Journal of Medicine. 357:1775-1777
Determination of time to onset and rate of action of insulin products: importance and new approaches
Publikováno v:
Journal of pharmaceutical sciences. 102(1)
One important aspect of insulin drug development is to ascertain that short-acting insulins mimic the normal mealtime insulin release in healthy subjects. Therefore, it is important to identify metrics that allow identification of unique characterist
Publikováno v:
Reviews in endocrinemetabolic disorders. 11(1)
All medications currently approved by the Food and Drug Administration (FDA) for the treatment of type 2 diabetes mellitus are indicated to improve glycemic control. Since 1995, FDA has used HbA1c as the primary basis for approval of these therapies
Autor:
Curtis Rosebraugh, Mary H. Parks
Publikováno v:
The New England journal of medicine. 362(9)
On January 25, the FDA approved liraglutide, a glucagon-like-peptide-1 receptor agonist that can improve glycemic control in adults with type 2 diabetes. Drs. Mary Parks and Curtis Rosebraugh discuss the benefits and potentially serious safety concer